News
Feed
Events
Feed
News
+ Events
Feed

Epigenomics AG

  • ISIN DE000A37FT41
  • Country Deutschland

Latest News

14 March 2024

08:00 Corporate

Epigenomics AG

Corporate

Epigenomics AG publishes financial results for fiscal year 2023

12 March 2024

08:51 Total Voting Rights

Epigenomics AG

Total Voting Rights

Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

6 March 2024

09:22 Advance Financial Reports

Epigenomics AG

Advance Financial Reports

 

15 February 2024

10:00 Corporate

Epigenomics AG

Corporate

Epigenomics AG: Jochen Hummel appointed to the Supervisory Board to replace Heikki Lanckriet

31 January 2024

15:30 Corporate

Epigenomics AG

Corporate

Epigenomics AG: Supervisory Board of Epigenomics AG appoints Hansjörg Plaggemars as member of the Executive Board

26 January 2024

13:16 Corporate

Epigenomics AG

Corporate

Epigenomics AG: Resignation of Supervisory Board Member Dr Heikki Lanckriet (PhD)

18 January 2024

16:05 Total Voting Rights

Epigenomics AG

Total Voting Rights

Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

30 November 2023

09:44 Other Capital Market Information DE

Epigenomics AG

Other Capital Market Information
DE

Veröffentlichung gemäß § 50 WpHG mit dem Ziel der europaweiten Verbreitung

22 November 2023

11:09 Total Voting Rights

Epigenomics AG

Total Voting Rights

Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

30 October 2023

15:49 Ad-hoc

Epigenomics AG

Ad-hoc

Epigenomics AG: Executive Board member Jens Ravens leaves the Company on April 30, 2024

27 October 2023

13:45 Total Voting Rights

Epigenomics AG

Total Voting Rights

Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

18 October 2023

14:53 Total Voting Rights

Epigenomics AG

Total Voting Rights

Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

10 October 2023

21:10 Corporate

Epigenomics AG

Corporate

Epigenomics AG Announces Closing of Agreement on the Acquisition of Almost All of the Company’s Assets and Adjustment of Guidance for 2023

20:56 Ad-hoc

Epigenomics AG

Ad-hoc

Epigenomics AG: Closing of Agreement on the Acquisition of Almost All Assets and Adjustment of Guidance for 2023

11 September 2023

15:54 Ad-hoc

Epigenomics AG

Ad-hoc

Epigenomics AG: Approval by the Extraordinary General Meeting of the acquisition of almost all assets and corresponding change of the statutory purpose of the Company

5 September 2023

17:20 Corporate

Epigenomics AG

Corporate

Epigenomics AG: Pareto and Warburg publish analyst research reports

12:23 Voting Rights Announcements DE

Epigenomics AG

Voting Rights Announcements
DE

 

10 August 2023

08:00 Corporate

Epigenomics AG

Corporate

Epigenomics AG publishes financial results for the first six months 2023

8 August 2023

16:55 Advance Financial Reports

Epigenomics AG

Advance Financial Reports

 

2 August 2023

10:36 Ad-hoc

Epigenomics AG

Ad-hoc

Epigenomics AG: Capital reduction planned at a ratio of 5 : 1

24 July 2023

18:40 Corporate

Epigenomics AG

Corporate

Epigenomics AG Announces Successful Agreement on the Acquisition of Significant Assets

18:29 Ad-hoc

Epigenomics AG

Ad-hoc

Epigenomics AG: Agreement on the Acquisition of Almost All Assets

12 June 2023

10:21 Ad-hoc

Epigenomics AG

Ad-hoc

Epigenomics AG: Negotiations on the Acquisitions of Almost All Assets

31 May 2023

08:00 Corporate

Epigenomics AG

Corporate

​​​​​​​Epigenomics AG Reports Financial Results for the First Quarter of 2023

19 May 2023

18:00 Corporate

Epigenomics AG

Corporate

Epigenomics AG: Member of the Executive Board and Chief Scientific Officer Andrew Lukowiak Resigns

17:48 Ad-hoc

Epigenomics AG

Ad-hoc

Epigenomics AG: Changes in the Management

28 April 2023

08:00 Corporate

Epigenomics AG

Corporate

​​​​​​​Epigenomics AG publishes financial results for fiscal year 2022

26 April 2023

11:46 Total Voting Rights

Epigenomics AG

Total Voting Rights

Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

12 April 2023

20:05 Corporate

Epigenomics AG

Corporate

Epigenomics AG: Chief Executive Officer Greg Hamilton Resigns

19:56 Ad-hoc

Epigenomics AG

Ad-hoc

Epigenomics AG: Changes in the Management

Upcoming Events

29

May 24

Epigenomics AG

Annual General Meeting

30

Sep 24

Epigenomics AG

Publication half-yearly financial report